showed that COL4A1 and COL4A2 as well as APP, TREX1 and HTRA1 were much less frequent than pathogenic variants in NOTCH3 in patients suffering from cerebral small vessel disease (CSVD) advised on genetic testing [14]. The gene discussed is COL4A1; the disease is cerebral small vessel disease.